Back to Results
First PageMeta Content
Biology / Ian Frazer / Gardasil / HPV vaccine / Cervarix / Human papillomavirus / Cervical cancer / Merck & Co. / Wart / Papillomavirus / Medicine / Microbiology


GARDASIL COMMERCIALISATION STORIES A GLOBAL SOLUTION TO REDUCING CERVICAL CANCER
Add to Reading List

Document Date: 2014-09-16 00:06:43


Open Document

File Size: 205,89 KB

Share Result on Facebook

City

Seattle / Melbourne / /

Company

Merck & Co. Inc. / UniQuest / GlaxoSmithKline / CSL UniQuest License / Pharmaceutcials Pty Limited / /

Country

New Zealand / United States / Canada / Australia / /

Currency

USD / /

/

Event

Patent Filing / Patent Issuance / Business Partnership / FDA Phase / Company Expansion / Funding / Person Communication and Meetings / /

Facility

Georgetown University / The University of Queensland / /

IndustryTerm

biotechnology / university technologies / final products / magnetic resonance imaging machines / pharmaceutical / image correction technology / cervical cancer vaccine technology / technology transfer / cervical cancer vaccine product / /

MedicalCondition

cervical cancers / HPV infection / genital warts / common cancer / cancer / HPV / cervical cancer / serious disease / high-grade cervical intraepithelial neoplasia / future infection / DISEASE Cancer / /

Organization

Federal Drug Administration / US Patent and Trademark Office / Georgetown University in America / Gates Foundation / World Health Organisation / Dr Jian Zhou UQ Faculty / University of Queensland / US Federal Court / /

Person

Ian Frazer / Jian Zhou / Mark Ashton / /

/

Position

researcher / Professor / Director / /

Product

Cervarix / GlaxoSmithKline / Federal Drug / /

ProvinceOrState

Queensland / /

Technology

university technologies / biotechnology / HPV technology / UQ technologies / cervical cancer vaccine technology / magnetic resonance imaging / image correction technology / /

URL

www.uniquest.com.au / /

SocialTag